Indoco Remedies rose 1.69% to Rs 231.4 after consolidated net profit spurted 71.62% to Rs 9.01 crore on 10% rise in total revenue from operations to to Rs 289.35 crore in Q3 December 2019 as against Q3 December 2018.
Consolidated profit before tax jumped 189% to Rs 11.07 crore in Q3 December 2019 as against Rs 3.83 crore in Q3 December 2018.
Commenting on Q3 resultsof the company, Aditi Panandikar, Managing Director, Indoeo Remedies, said, "During the third quarter, India Business continued the growth momentum by clocking a growth of 17%. International business registered a growth of 21 % in the third quarter. Considering the planned product launches in US, we expect the growth momentum in International business to continue".
Indoco Remedies is a fully integrated, research-oriented pharma company with presence in 55 countries.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
